Mitral Regurgitation - Valvular Heart Disease Guidelines

Mitral Regurgitation Guidelines App

ACC/AHA Valvular Heart Disease - Mitral Regurgitation GUIDELINES Apps brought to you charge courtesy of Guideline Central and Abbott Vascular.

Issue link: https://eguideline.guidelinecentral.com/i/674356

Contents of this Issue

Navigation

Page 12 of 15

Figure 1. Indications for Surgery for MR MR Primary MR Secondary MR Severe MR • Vena contracta ≥0.7 cm • RVol ≥60 mL • RF ≥50% • ERO ≥0.4 cm 2 • LV dilation Progressive MR (stage B) • Vena contracta <0.7 cm • RVol <60 mL • RF <50% • ERO <0.4 cm 2 • CAD Rx • HF Rx • Consider CRT Symptomatic (stage D) Asymptomatic (stage C) LVEF 30%-≤60% or LVESD ≥40 mm (stage C2) LVEF >60% and LVESD <40 mm (stage C1) New onset AF or PASP >50 mm Hg (stage C1) Likelihood of successful repair >95% and Expected mortality <1% Periodic Monitoring MV Repair (IIa) MV Surgery a (I) NO YES MV Surgery a (IIb) LVEF >30% NO YES Symptomatic severe MR (stage D) Asymptomatic severe MR (stage C) Progressive MR (stage B) MV Surgery a (IIb) Periodic Monitoring Persistent NYHA class III-IV symptoms a MV repair is preferred over MVR when possible. 11

Articles in this issue

view archives of Mitral Regurgitation - Valvular Heart Disease Guidelines - Mitral Regurgitation Guidelines App